Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Coversyl |
| Active Ingredient: | Perindopril erbumine 2mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Servier Laboratories NZ Limited |
| Manufacturers: | Servier (Ireland) Industries Limited, Wicklow, Ireland Les Laboratoires Servier Industrie, Gidy, France |
| Product: | Coversyl |
| Active Ingredient: | Perindopril erbumine 4mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Servier Laboratories NZ Limited |
| Manufacturers: | Servier (Ireland) Industries Limited, Wicklow, Ireland Les Laboratoires Servier Industrie, Gidy, France |
| Product: | Coversyl |
| Active Ingredient: | Perindopril erbumine 8mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Servier Laboratories NZ Limited |
| Manufacturers: | Servier (Ireland) Industries Limited, Wicklow, Ireland Les Laboratoires Servier Industrie, Gidy, France |
| Product: | Yondelis |
| Active Ingredient: | Trabectedin 0.25mg |
| Dosage Form: | Powder for infusion |
| New Zealand Sponsor: | Specialised Therapeutics Limited |
| Manufacturers: | Baxter Oncology GmbH, Halle, Germany Cenexi-Laboratories Thissen SA, Braine- L’Alleud, Belgium GP Pharm SA, Barcelona, Spain |
| Product: | Yondelis |
| Active Ingredient: | Trabectedin 1mg |
| Dosage Form: | Powder for infusion |
| New Zealand Sponsor: | Specialised Therapeutics Limited |
| Manufacturers: | Baxter Oncology GmbH, Halle, Germany Cenexi-Laboratories Thissen SA, Braine-L’Alleud, Belgium GP Pharm SA, Barcelona, Spain |
Dated this 15th day of February 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).